We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Discretionary 10.52%
3 Financials 9.9%
4 Healthcare 8.91%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBAS
6076
DELISTED
Optibase Ltd
OBAS
$1K ﹤0.01%
72
KACLU
6077
DELISTED
Kairous Acquisition Corp. Limited Unit
KACLU
$1K ﹤0.01%
+68
New +$688
CBRGU
6078
DELISTED
Chain Bridge I Units
CBRGU
$1K ﹤0.01%
+81
New +$816
PUCKU
6079
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
$1K ﹤0.01%
99
FHLTU
6080
DELISTED
Future Health ESG Corp. Unit
FHLTU
$1K ﹤0.01%
125
-399
-76% -$3.99K
FICVU
6081
DELISTED
Frontier Investment Corp Units
FICVU
$1K ﹤0.01%
55
OPA.U
6082
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$1K ﹤0.01%
+80
New +$842
MEOA
6083
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
$1K ﹤0.01%
+86
New +$857
LVACU
6084
DELISTED
LAVA Medtech Acquisition Corp. Unit
LVACU
$1K ﹤0.01%
+60
New +$607
GEEXU
6085
DELISTED
Games & Esports Experience Acquisition Corp. Unit
GEEXU
$1K ﹤0.01%
+54
New +$547
PTOCU
6086
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
$1K ﹤0.01%
+76
New +$760
EVK
6087
DELISTED
Ever-Glory International Group, Inc.
EVK
$1K ﹤0.01%
380
-2,211
-85% -$6.03K
IMH
6088
DELISTED
Impac Mortgage Holdings Inc.
IMH
$1K ﹤0.01%
693
-3,923
-85% -$5K
PMGMU
6089
DELISTED
Priveterra Acquisition Corp. II Unit
PMGMU
$1K ﹤0.01%
100
ABX
6090
Abacus Global Management
ABX
$869M
-619
Closed -$6K
ABVC icon
6091
ABVC BioPharma
ABVC
$23.5M
-349
Closed -$8K
ACXP icon
6092
Acurx Pharmaceuticals
ACXP
$6.4M
-35
Closed -$4K
ZNB
6093
Zeta Network Group
ZNB
$2.6M
0
-$1K
ADIL
6094
Adial Pharmaceuticals
ADIL
$9.52M
0
ADTX
6095
DELISTED
ADITXT INC
ADTX
0
-$1K
ADVWW
6096
DELISTED
Advantage Solutions Warrant
ADVWW
$0 ﹤0.01%
23
AEHL icon
6097
Antelope Enterprise Holdings
AEHL
$5.98M
0
-$7K
AEI icon
6098
Alset
AEI
$40.1M
-153
Closed -$7K
AFB
6099
AllianceBernstein National Municipal Income Fund
AFB
$315M
$0 ﹤0.01%
2
-19
-90% -$283
AFMC icon
6100
First Trust Active Factor Mid Cap ETF
AFMC
$198M
-10,572
Closed -$263K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.